BioDrone Therapeutics Inc.
  • Home
  • About Us
  • Our Sciences
    • Cell-Derived Vesicle
    • BioDrone™ Platform
    • Manufacturing
    • Intellectual Properties
  • Pipeline
  • Publications
    • Publications
    • Posters & Presentations
  • Business
    • Business Model
    • Open Innovation
  • News
    • Press Releases
  • Plus
    • Home
    • About Us
    • Our Sciences
      • Cell-Derived Vesicle
      • BioDrone™ Platform
      • Manufacturing
      • Intellectual Properties
    • Pipeline
    • Publications
      • Publications
      • Posters & Presentations
    • Business
      • Business Model
      • Open Innovation
    • News
      • Press Releases
BioDrone Therapeutics Inc.
  • Home
  • About Us
  • Our Sciences
    • Cell-Derived Vesicle
    • BioDrone™ Platform
    • Manufacturing
    • Intellectual Properties
  • Pipeline
  • Publications
    • Publications
    • Posters & Presentations
  • Business
    • Business Model
    • Open Innovation
  • News
    • Press Releases
data:image/gif;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=

BIODRONE PLATFORM TECHNOLOGY

BIODRONE PLATFORM TECHNOLOGY BIODRONE PLATFORM TECHNOLOGY BIODRONE PLATFORM TECHNOLOGY


Smart drug delivery platform based on cell-derived vesicles 

Learn more

BIODRONE PLATFORM TECHNOLOGY

BIODRONE PLATFORM TECHNOLOGY BIODRONE PLATFORM TECHNOLOGY BIODRONE PLATFORM TECHNOLOGY


Smart drug delivery platform based on cell-derived vesicles 

Learn more

Latest News

MDimune Named as a Finalist in the Prestigious 2023 Edison Awards™

MDimune announced the development of the GMP manufacturing process CDVs in the latest publication

MDimune announced a collaboration with Hanyang University through the 3rd BioDrone™ Award

Feb 22, 2023  BioDrone™ next-generation drug delivery platform honored for excellence alongside other innovators and innovations in the Health, Medical & Biotech category

Find out more

MDimune announced a collaboration with Hanyang University through the 3rd BioDrone™ Award

MDimune announced the development of the GMP manufacturing process CDVs in the latest publication

MDimune announced a collaboration with Hanyang University through the 3rd BioDrone™ Award

Jan 26, 2023  MDimune Inc. announced funding of two research projects focusing on next-generation drug delivery and novel therapeutics. 

Find out more

MDimune announced the development of the GMP manufacturing process CDVs in the latest publication

MDimune announced the development of the GMP manufacturing process CDVs in the latest publication

MDimune announced the development of the GMP manufacturing process CDVs in the latest publication

Jan 5, 2023   MDimune Inc. announced the publication of data in the Journal of Extracellular Biology showing the development of the Good Manufacturing Practice (GMP)-compliant manufacturing process of CDVs and their biological activities. 

Find out more

About Us

BioDrone™ Platform Technology

BioDrone™ Platform Technology

BioDrone™ Platform Technology

Groundbreaking drug delivery platform that precisely delivers various drugs to targeted lesions by loading them into cell-derived vesicles (CDVs) derived from human cells.

Business Model

BioDrone™ Platform Technology

BioDrone™ Platform Technology

MDimune is currently seeking partners for R&D collaborations that utilize the BioDrone™ (CDVs) platform for next-generation cell therapies or targeted payload delivery.

Open Innovation

BioDrone™ Platform Technology

Open Innovation

Platform Inside Development Outside (PIDO) model to collaborate with pharma/biotech partners in diverse therapeutic areas (cancer, rare diseases, CNS disorders, etc.).

Photo Gallery

Cryo-TEM images of CDVs and EVs

    Copyright © 2022 BioDrone Therapeutics Inc. - All Rights Reserved.

    • Contact